Compare Hims and Hers Health Inc (HIMS) vs State Street SPDR S&P Homebuilders ETF (XHB) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Hims and Hers Health Inc vs State Street SPDR S&P Homebuilders ETF — how do they compare? Hims and Hers Health Inc trades at $30.92 (market cap $6.55B), while State Street SPDR S&P Homebuilders ETF trades at $94.77 (market cap $1.49B). The key difference: Hims and Hers Health Inc is far larger — about 4.4× State Street SPDR S&P Homebuilders ETF's market cap, and Hims and Hers Health Inc is trading nearer its 52-week high, State Street SPDR S&P Homebuilders ETF nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Hims and Hers Health Inc for 21 Days and State Street SPDR S&P Homebuilders ETF for 33 Days on average.
| HIMS | XHB | |
|---|---|---|
Market Cap | $6.55B | $1.49B |
Volume | 14,842,814 | 2,445,587 |
Sector | Health | Broad Market / Factor |
52-Week High | $62.76 | $121.36 |
52-Week Low | $14.52 | $94.77 |
Typical Hold Time | 21 Days | 33 Days |
Enterprise Value | $7.25B | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
HIMS stock trades at $28.06, down 5.01% on the day, amid a bearish technical signal and negative earnings surprises. The company reported a net loss of $142 million in 2026, with a negative net income margin of -5.51%, despite revenue growth to $2.6 billion. Multiple securities class action lawsuits filed in October 2026 create significant legal overhang, while analyst consensus remains mixed with a $32.17 price target but only 35% buy ratings.
The outlook is clouded by profitability challenges and legal risks, though revenue growth offers a potential catalyst if margins improve. Investors face substantial downside risk from ongoing litigation and weak earnings, offset by analyst price targets suggesting modest upside from current levels if operational execution improves.
XHB (SPDR S&P Homebuilders ETF) trades at $95.66, up 0.81% with a bearish technical signal from moving averages. The ETF faces headwinds from rising mortgage rates above 7% but shows potential catalysts from new housing legislation and institutional interest. Recent news highlights mixed housing data with June new home sales rising 1.6% while existing home sales declined 2.4%, creating uncertainty in the housing sector.
The homebuilder ETF presents a contrarian opportunity amid sector weakness, with historical valuation signals suggesting potential rebounds. Key risks include persistent high mortgage rates and housing affordability challenges, while positive catalysts include institutional accumulation and government housing support measures.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Hims and Hers Health Inc
Hims & Hers is a multi-specialty telehealth platform that provides personalized health and wellness products. It offers access to medical providers and treatments for hair loss, sexual health, and skincare.
Read more on HIMS →About State Street SPDR S&P Homebuilders ETF
XHB invests in the U.S. homebuilding industry and related sectors. It provides equal-weighted exposure to homebuilders, building products, and home improvement retailers like Home Depot, Lowe's, and Builders FirstSource.
Read more on XHB →
